| Prev Close | 7.17 |
| Day Low/High | 7.13 / 7.38 |
| 52 Wk Low/High | 4.62 / 15.83 |
Cronos Group Inc (CRON)
7.29
NASDAQ
| Exchange | NASDAQ |
| Shares Outstanding | 371.66B |
| Market Cap | 2.67B |
| P/E Ratio | 5.66 |
| Div & Yield | N.A. (N.A) |
Latest News
After Smoke Clears, Pot Industry Could See M&A Activity Light Up
Real Money tapped an industry expert to discuss the outlook for buying and selling of cannabis companies.
Jim Cramer: Here's One Specialized Chain That's Growing Like a Weed
If the Democrats sweep, you have perhaps the best single stock in the market.
Fire Up Your Portfolio With This Dividend King
Altria has future growth potential, over 50 years of dividend increases and a high yield exceeding 8%.
Play 'Spot the Themes' With Cannabis, Electric Cars and Biotech
It continues to be a very good market for aggressive traders that focus on stock-picking and sectors.
6 Cannabis Stock Plays Investors Should Know About
This six-pack from investment specialists includes a REIT and a software provider specializing in the industry.
Canadian Cannabis Firms Addressing Illegal Markets
These companies initially seemed to believe that regulators and law enforcement would drive out the illicit market dealers. That hasn't happened.
Which Cannabis Cos. Will Survive? The Ones With a Pot of Cash
Here are three names that should drag on as other financially strapped names risk going up in smoke.
My 'Trade of the Week' Is Smoking Hot; Here's an Update
Last week's "Trade of the Week" -- a basket of speculative cannabis stocks -- was intended, as I wrote, through the end of the year. In looking at the buy levels, it was a very successful idea -- with three of the stocks rising by more than 20% as ...
A Look-See and Some Market Highlights in My Portfolio Today
Some market highlights today (in my book): * Kraft Heinz sneaking back to the old highs. *Cronos Group and Canopy Growth Corp (a helluva trade off of the morning lows) are cannabis leadership. * Cannabis spec basket still ++. * The iShares Barclays ...
Cannabis High
Cannabis stocks are continuing to get their groove back this morning - with good gains in , , , and .
Let's Get Chai!
Here is your Marijuana Moment. Last week, my Trade of the Week (and a half!) was a basket of cannabis stocks -- and I moved to large sized in all of them during the week (Note: The stocks started to roll higher on Friday): My package includes  ($7.0...
Trade of the Week - A Package of Speculative Cannabis Stocks
* My package includes ($7.00), ($5.69), ($5.45), ($2.25) and ($8.15) * It is likely that the maximum tax selling pressure is now virtually over * While technically "The Trade of the Week" - this is my favorite group to benefit from the "January Effe...
Adding to Cannabis
* In the hope for a "January Effect" after tax loss selling in December I added to ($7.82), ($6.70), ($5.90), ($5.29) and ($2.19) today.
Cannabis a Rising Star in Morningstar Mag
Morningstar Magazine offers insight into future growth potential for cannabis industry and stocks.
Don't Fight the Trend on These 3 Cannabis Stocks
A look at what the weekly charts of three big cannabis names are saying.
New Buy (and Short) Levels
* My revised levels I don't want there to be any ambiguity about the size of my positions or about my buy and short levels as I strive for as much transparency as possible. "When the time comes to buy, you won't want to." - Walter Deemer "When the t...
Cannabis Moves
I am adding names to my basket of cannabis stocks - including ($8.80), and a number of very small speculative stocks that are too racy to name.
Cronos Group Is Still Coming Down From Its High
Shares of the cannabis company are likely to drift lower in the weeks ahead.
Cronos Group Could Break Key Moving Averages - Protect Long Positions
Let's look at the chart of CRON.
Morningstar High on Pot Growth, Sees U.S. Going Legal by 2023
Analysts say nation will turn a new leaf, changing federal law within a few years, as cannabis industry expected to grow big time over next decade.
Would You Rather Have an Executive Team Managing the Company or the Stock Price?
It all comes down to matching my time frame.
OrganiGram Could Climb Higher, but You Need Discipline Before Buying
Here's how to play OGI stock right now.
5 Cannabis ETFs to Fire Up Your Portfolio
Two of them are brand new.
Prohibition and the Paradoxical Proclivity of Cannabis Consumption
Is prohibition the real factor propping up projections for demand and pricing in the cannabis market?
Should Investors Buy the Dip in Canopy Growth Stock?
Canopy's earnings losses could just be a stepping stone to becoming the industry leader.
Canopy Growth Now Has to be Considered the Leader in the Canadian Cannabis Space
CGC has the best chance to transition to broader success should the U.S. ever go the route of legalization beyond the state level.
